Skip to main content

February 2012 Vol 5, No 1, Special Issue

Conference Highlights ASH
High Morbidity Burden Borne Years Later by Survivors of Transplant
Caroline Helwick, Caroline Helwick
Read More
Leukemia, Oncology
Obinutuzumab Could Give Rituximab a Run for Its Money in Relapsed Indolent NHL
Read More
Leukemia, Oncology
Maintenance Rituximab May Be Unnecessary in FL
Caroline Helwick, Caroline Helwick
Read More
Multiple Myeloma, Multiple Myeloma, Oncology
Monoclonal Antibody Elotuzumab Promising in Multiple Myeloma
Read More
Multiple Myeloma, Multiple Myeloma, Multiple Myeloma, Oncology
Pomalidomide a Promising New Immunomodulatory Drug for Multiple Myeloma
Read More
Leukemia, Oncology
Investigational Blinatumomab Puts BiTE on Acute Lymphoblastic Leukemia
Neil Canavan
Read More
Radiologic Surveillance for Early-Stage Hodgkin Lymphoma an Unnecessary Expense?
Caroline Helwick, Caroline Helwick
Read More
A Large Study Sheds Light on the Cost of Managing NHL
Caroline Helwick
Read More
Second-Generation TKIs Have Potential to Cure CML
Read More
Hematologists Are Told to Get Ready for ACOs
Neil Canavan, Neil Canavan
Read More
Page 2 of 3
Results 11 - 20 of 29